<?xml version="1.0" encoding="UTF-8"?>
<ref id="B97">
 <label>97.</label>
 <mixed-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Tsai</surname>
    <given-names>CW</given-names>
   </name>
   <name>
    <surname>Morris</surname>
    <given-names>S</given-names>
   </name>
  </person-group>. 
  <article-title>Approval of raxibacumab for the treatment of inhalation anthrax under the US food and drug administration animal rule</article-title>. 
  <source>Front Microbiol</source>. (
  <year>2015</year>) 
  <volume>6</volume>:
  <fpage>1320</fpage>. 
  <pub-id pub-id-type="doi">10.3389/fmicb.2015.01320</pub-id>
  <?supplied-pmid 26648915?>
  <pub-id pub-id-type="pmid">26648915</pub-id>
 </mixed-citation>
</ref>
